Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Outlook Therapeutics (OTLK) EBT Margin (2016 - 2025)

Outlook Therapeutics (OTLK) has disclosed EBT Margin for 7 consecutive years, with 16175.93% as the latest value for Q3 2025.

  • Quarterly EBT Margin changed N/A to 16175.93% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 6709.3% through Dec 2025, down 914821.0% year-over-year, with the annual reading at 4526.01% for FY2025, 691323.0% down from the prior year.
  • EBT Margin for Q3 2025 was 16175.93% at Outlook Therapeutics, up from 1338.75% in the prior quarter.
  • The five-year high for EBT Margin was 16175.93% in Q3 2025, with the low at 1338.75% in Q2 2025.